NS · Healthcare

Vivimed Labs Ltd (VIVIMEDLAB)

Pharmaceuticals & Biotechnology

Vivimed Labs Ltd (VIVIMEDLAB) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $490.00M, P/E ratio is -1.47, net margin is -81.4%, dividend yield is 6.77%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for VIVIMEDLAB

Market cap

$490.00M

P/E ratio

-1.47

Net margin

-81.4%

Dividend yield

6.77%

Vivimed Labs Ltd (VIVIMEDLAB) — FAQ

What is Vivimed Labs Ltd's market cap?

Vivimed Labs Ltd (VIVIMEDLAB) has a reported market cap of $490.00M (data as of 2026-07-10).

What is VIVIMEDLAB's P/E ratio?

The price-to-earnings (P/E) ratio for Vivimed Labs Ltd (VIVIMEDLAB) is -1.47 (data as of 2026-07-10).

Does Vivimed Labs Ltd pay a dividend?

Vivimed Labs Ltd (VIVIMEDLAB) shows a reported dividend yield of 6.77%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Vivimed Labs Ltd in?

Vivimed Labs Ltd (VIVIMEDLAB) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is VIVIMEDLAB listed on?

VIVIMEDLAB is listed on NS.

What is Vivimed Labs Ltd's net margin?

Vivimed Labs Ltd (VIVIMEDLAB) reports a net margin of -81.4% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)